Skip to main content
. 2022 Apr 23;11(9):2363. doi: 10.3390/jcm11092363

Table 1.

Sociodemographic data and characteristics of the sample.

N = 90 N = 90
Variable Categories CT+ N (%) CT− N (%)
Marital status Married 64 (71.7) 66 (73.3)
Single 9 (10) 12 (13.3)
Divorced 6 (6.7) 8 (9)
Widowed 11 (12.2) 4 (4.4)
Education level No studies 9(10) 5 (5.5)
Elementary school 30 (33.3) 25 (27.8)
Middle school 13 (14.4) 11 (12.2)
High school 15 (16.7) 24 (26.7)
Higher education 23 (25.6) 25 (27.8)
Employment situation Currently in employment 8 (8.9) 12 (13.3)
Temporary sick leave 43 (47.8) 31 (34.4)
Permanent sick leave 9 (10) 5 (5.6)
Unemployed 20 (22.2) 25 (27.8)
Retired 10 (11.1) 17 (18.9)
Tumor staging 0 4 (4.4) 5 (5.6)
I 18 (20) 39 (43.3)
II 31 (34.5) 30 (33.3)
III 24 (26.7) 8 (8.9)
IV 13 (14.4) 8 (8.9)
Grade 1 18 (20) 25 (27.8)
2 23 (25.6) 40 (44.4)
3 49 (54.4) 49 (27.8)
Molecular subtype Luminal A/Luminal B HER2 negative-like 47 (52.2) 60 (66.7)
Luminal B HER2 positive-like/HER2-type 33 (36.7) 30 (33.3)
Triple negative 10 (11.1) 0 (0)3
Menopause Natural 42 (46.7) 52 (57.8)
Drug-induced menopause 25 (27.8) 6 (6.7)
Intervention-induced menopause 3 (3.3) 9 (10)
Reproductive stage 20 (22.2) 23 (25.5)
Surgical treatment Conservative surgery 41 (45.6) 76 (84.5)
Uni- or bilateral mastectomy 23 (25.5) 11 (12.2)
Without surgical treatment 26 (28.9) 3 (3.3)
Chemotherapy cycles Chemotherapy cycles < 4 53 (58.9)
Chemotherapy cycles ≥ 4 37 (41.1)